Location: New York, NY
CIK: 0001609251 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value: $282M
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| EXEL | EXELIXIS INC | 1,899,079 | $45.56M | 16.2% | $18.49 | +17.6% | — | 30161Q104 |
| UTHR | UNITED THERAPEUTICS CORP | 200,872 | $44.17M | 15.7% | $127.97 | +80.1% | — | 91307C102 |
| BIIB | BIOGEN INC | 160,480 | $41.53M | 14.7% | $267.94 | -8.3% | — | 09062X103 |
| REGN | REGENERON PHARMACEUTICALS | 47,256 | $41.5M | 14.7% | $342.96 | +138.8% | — | 75886F107 |
| CAH | CARDINAL HEALTH INC | 281,476 | $28.37M | 10.1% | $56.53 | +69.3% | — | 14149Y108 |
| — | TARO PHARMACEUTICAL INDUS | 646,453 | $27.01M | 9.6% | $70.84 | — | — | M8737E108 |
| ALKS | ALKERMES PLC | 918,038 | $25.47M | 9.0% | $18.83 | +38.0% | — | G01767105 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 100,000 | $12.3M | 4.4% | $124.79 | 0.0% | — | G50871105 |
| SNY | SANOFI-ADR | 150,400 | $7.479M | 2.7% | $49.73 | — | — | 80105N105 |
| ENTA | ENANTA PHARMACEUTICALS INC | 742,824 | $6.99M | 2.5% | $41.72 | -77.7% | — | 29251M106 |
| MASI | MASIMO CORP | 8,000 | $938K | 0.3% | $93.21 | 0.0% | — | 574795100 |
| — | MURAL ONCOLOGY PLC | 90,833 | $538K | 0.2% | $5.92 | — | — | G63365103 |